Trial Profile
A phase 1/2 open-label, dose-escalation study with single ascending dose and subsequent multiple ascending dose arms of mRNA-3283
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jul 2018
Price :
$35
*
At a glance
- Drugs MRNA-3283 (Primary)
- Indications Phenylketonuria
- Focus Adverse reactions
- 16 Jul 2018 New trial record